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Abstract Infrared spectroscopy was used to evaluate the effect 
of non-iron porphyrins (protoporphyrin IX and haematoporphyr-
in) on haematin polymerisation to ß-haematin at acidic pH. Both 
molecules effectively inhibited the reaction, with haematopor-
phyrin 6 times as active as protoporphyrin IX. We postulated 
that the interaction between the pi electron system of porphyrin 
rings leads to the formation of pi - pi adducts, which inhibit 
polymer elongation in the same way as antimalarial drugs (e.g., 
chloroquine); the presence of hydroxyl groups able to bind haem 
iron enhances activity. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Haem (ferriprotoporphyrin IX) is a by-product of haemo-
globin digestion, a process which takes place in an acidic 
compartment of intraerythrocyte-stage malaria parasites [1]. 
Haem must be detoxified by assembly into insoluble malaria 
pigment (haemozoin): one carboxylic oxygen of the propio-
nate side chain of one haem molecule is coordinated to the 
central iron of an adjacent haem subunit to form oxygen-iron 
bonds [2-Λ]. Notwithstanding uncertainties about the details 
of the natural process in the parasite [5], polymerisation of 
soluble haematin has been shown to occur spontaneously in 
vitro at acidic p H [2,6,7]. The synthetic polymer, ß-haematin, 
retains the solubility properties and the spectroscopic charac-
teristics of native haemozoin [2,8]. 
Quinoline antimalarials (e.g., chloroquine, amodiaquine 
and quinine) act principally by forming adducts with ferripro-
toporphyrin IX, thus blocking haemozoin formation [6,7,9]. 
Mössbauer spectroscopy data indicate that in the haem-qui-
noline complex the iron atom couples antiferromagnetically 
either directly or through the pi electron system of chloroquine 
[10]. This observation let us hypothesize that any molecule 
able to intercalate or form pi - pi adducts with haem could in-
hibit haematin polymerisation. This may provide a rationale 
for screening new antimalarials. 
To verify this hypothesis, we evaluated the inhibitory activ-
ity of non-iron porphyrins (protoporphyrin IX and haemato-
porphyrin), on the polymerisation of haematin to ß-haematin 
at acidic p H by infrared (IR) spectroscopy. Protoporphyrin 
IX is a protoporphyrin isomer identical to haem (ferriproto-
porphyrin IX) except that it lacks the central iron a tom; hae-
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matoporphyrin is a non-iron porphyrin with two a-hydroxy-
ethyl side chains (see Fig. 1). Both molecules share with 
haematin the possibility of giving pi - pi adducts [11]. 
2. Materials and methods 
Haemin (ferriprotoporphyrin IX chloride), protoporphyrin IX, hae-
matoporphyrin and chloroquine diphosphate were purchased from 
Sigma-Aldrich (Milan, Italy). ß-Haematin was synthesized in accord-
ance with the procedure reported by Egan et al. [6] with slight mod-
ifications. Briefly, haematin (ferriprotoporphyrin IX hydroxide) was 
prepared by dissolving 15 mg of haemin in 3 ml of 0.1 M NaOH. 
Then, a solution containing 0.3 ml of 1 M HC1 plus 1.74 ml of 12.9 M 
sodium acetate (pH 5.00) pre-warmed at 60°C, was added. After 60' 
of incubation at 60°C, the reaction mixture was filtered over Type HA 
Millipore filters (0.45 μηι) and washed extensively with distilled water. 
Protoporhyrin IX and haematoporphyrin were dissolved in 3 ml 
NaOH 0.1 M in the presence of 15 mg haemin at different molar 
ratios (haemin/porphyrin ratios 1:0; 1:0.5; 1:1; 1:2; 1:3): the mix-
ture was incubated as described above. Control inhibition of ß-hae-
matin formation was obtained by adding 3 equivalents of chloroquine 
to haemin, as described elsewhere [6,9]. The solid precipitate was then 
dried over phosphorus pentoxide under vacuum overnight and finally 
characterized FT-IR spectroscopy using a Jasco FT-IR spectrometer. 
To validate the sensitivity of FT-IR analyses 1 equivalent of solid 
ß-haematin, previously synthesised, was ground with 3 equivalents 
of porphyrins in KBr matrix and characterized by FT-IR spectro-
scopy. Native haemozoin, isolated from human erythrocyte cultures 
infected with Plasmodium falciparum, was used as control (purified by 
Dr. S. Picot, University of Grenoble, France). 
3. Results and discussion 
Haematin can polymerise chemically in 4.5 M acetate buffer 
at 60°C [6]. The reaction product was characterized by FT-
IR; this technique unequivocally distinguishes haematin from 
ß-haematin. Both the synthetic polymer and native haemozoin 
show bands at 1662 and 1209 c m - 1 characteristic of the i r on -
carboxylate bonds [2], which are not present in the spectrum 
p = —CH2CH2COOH 
α-Haematin Protoporphyrin ΓΧ R = —CH=CH2 
Haematoporphyrin R = —CH-CH3 
OH 
Fig. 1. Chemical structure of porphyrins used in this study. 
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Fig. 2. A: Infrared spectra of haematin, synthetic ß-haematin, ob-
tained after 60' incubation in 4.5 M acetate, pH 5, 60°C, and native 
haemozoin, purified from cultures of P. falciparum. The characteris-
tic peaks of haemozoin and ß-haematin at 1662 and 1209 cnT1 are 
marked with arrows, ß-haematin (bold line); haemozoin (line, me-
dium thickness); haematin (thin line). B: Infrared spectra of ß-hae-
matin or haematin polymerised in the presence of 3 equivalents of 
chloroquine. ß-haematin (bold line); haematin+chloroquine (thin 
line). 
of haematin (Fig. 2A). FT-IR is also a valid and reproducible 
method for studying the inhibition of haemozoin formation 
by antimalarial drugs, such as quinoline antimalarials [6]. As 
shown in Fig. 2B, the FT-IR spectra of the precipitate in the 
presence of 3 equivalents of chloroquine differ significantly 
from untreated controls: the characteristic peaks at 1662 
and 1209 cm - 1 are completely lost. 
FT-IR proved to be suited to visualizing the distinctive 
bands of ß-haematin even in the presence of large quantities 
of unpolymerised porphyrins: the infrared spectra of ß-hae-
matin mixed with 3 equivalents of protoporphyrin IX or hae-
matoporphyrin at the time of sample preparation can be seen 
in Fig. 3. Both spectra are superimposable on that of ß-hae-
matin. 
Different equivalents of protoporphyrin IX or haematopor-
phyrin added to haemin at the beginning of the reaction 
showed the ability to inhibit ß-haematin polymerisation. The 
characteristic peaks of ß-haematin disappeared progressively 
with increasing molar doses of protoporphyrin IX. Complete 
inhibition of ß-haematin formation was observed at a haemin/ 
protoporphyrin IX ratio of 1:3 (Fig. 4A). Haematoporphyrin 
was more effective in inhibiting polymerisation since it was 
active also at a molar ratio of 1:0.5 (Fig. 4B). 
Both iron- and non-iron-porphyrins undergo spontaneous 
dimerisation primarily due to pi-pi interactions between the 
electron rings of adjacent molecules [11]. The interactions be-
tween quinoline antimalarials and the haematin ring are also 
mediated by co-facial links, as demonstrated by Mössbauer 
spectroscopy studies [8,12]. Quinoline-type antimalarials from 
haem-drug complexes, whereby the quinoline ring lies parallel 
to the porphyrin ring [8,10]. Such adducts prevent haemozoin 
polymer extension [9]. The quinoline ring was reported to 
interact in a similar way with uroporphyrin I [13,14]. Our 
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Fig. 3. Comparison between the infrared spectra of ß-haematin and 
of ß-haematin ground together with 3 equivalents of haematopor-
phyrin or protoporphyrin IX in KBr matrix. The characteristic 
peaks of ß-haematin at 1662 and 1209 cm-1 are marked with 
arrows, ß-haematin (bold line); + protoporphyrin IX (line, medium 
thickness); + haematoporphyrin (thin line). 
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Fig. 4. A: Infrared spectra of ß-haematin or haematin polymerised 
in the presence of different equivalents of protoporphyrin IX, indi-
cated by lines in order of decreasing thickness: ß-haematin; + 1:1 
protoporphyrin IX; + 1:2 protoporphyrin IX; + 1:3 protoporphy-
rin IX. B: Infrared spectra of ß-haematin or haematin polymerised 
in the presence of 0.5 equivalents of haematoporphyrin. ß-haematin 
(bold line); + 1:0.5 haematoporphyrin (thin line). 
data substantiate the hypothesis that molecules able to give 
co-facial pi-pi interactions with haematin can interfere with 
haem polymerisation. 
The greater inhibitory activity of haematoporphyrin than of 
protoporphyrin IX could be attributed to two secondary hy-
droxy side groups in the benzylic position; the presence of 
hydroxy side groups in the quinoline antimalarial drugs, qui-
nine and quinidine, is also noteworthy. The crucial role of 
these groups for the antimalarial activity of 4-quinolinecarbi-
nolamine compounds was recently emphasised [15]. 
In conclusion, in this paper we show that non-iron porphy-
rins inhibit ß-haematin polymerisation by coordinating with 
haematin via co-facial pi-pi links. Potency increases in the 
presence of hydroxyl groups. Therefore, we postulate that 
compounds able to give both pi-pi link and binding between 
hydroxyl groups and haematin iron are best suited to form 
drug-haem complexes and thus to inhibit haem polymerisa-
tion and detoxification. 
These results are of potential relevance not only to the 
design of new antimalarials, but also to the treatment of dis-
orders of porphyrin metabolism, such as porphyrias. 
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